Literature DB >> 782982

Immunopathology of renal extracellular membranes in diabetes mellitus. Specificity of tubular basement-membrane immunofluorescence.

K Miller, A F Michael.   

Abstract

This study documents the presence of marked immunofluorescence for IgG and albumin in renal extracellular membranes, especially tubular basement membranes (TBM), of patients with severe diabetic nephropathy. A comprehensive immunofluorescent analysis was carried out on kidney tissue from 83 patients--Group I: 24 living normal renal allograft donors and two infants less than one week of age. Group II: 24 patients with severe nephropathy who had juvenile onset of diabetes 16 to 30 years previously and who ranged in age from 20 to 47 years. Group III: 33 patients with severe kidney disease of varied etiologies with an age range of five to 63 years. The sections were assayed for a variety of proteins (immunoglobulins, complement components, and tissue antigens). Kidney sections of all patients with severe diabetic nephropathy were readily distinguished from kidneys of other patients and normals by the intense linear staining of the extracellular membranes, especially the tubular basement membrane for IgG and and albumin. Dual-labeled studies using FITC anti-basement membrane (BM) and tetramethyl rhodamine (TMR) antialbumin demonstrated localization of the albumin predominantly to the outer but also the inner TBM while the BM antisera reacted more intensely with the inner membrane. There is no evidence that an immunologic process is responsible for these findings. These immunofluorescent findings are specific for severe diabetic nephropathy and may reflect structural changes in the renal extracellular membranes that permit entrapment of serum proteins, possibly due to changes in permeability.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782982     DOI: 10.2337/diab.25.8.701

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

Authors:  Tomohito Gohda; William H Walker; Pawel Wolkow; Jung Eun Lee; James H Warram; Andrzej S Krolewski; Monika A Niewczas
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-18

2.  Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus.

Authors:  R Mangili; G C Viberti; D Vergani
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

3.  Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Authors:  Amy R Wyatt; Mark R Wilson
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

4.  Lectin binding in membranoproliferative glomerulonephritis. Evidence for N-acetylglucosamine in dense intramembranous deposits.

Authors:  T E Nevins
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

5.  Albumin deposition in dermal capillary basement membrane in parents of type 1 (insulin-dependent) diabetic patients.

Authors:  B Chavers; D Etzwiler; J Barbosa; F H Bach; A F Michael
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

6.  Selective binding of IgG4 and other negatively charged plasma proteins in normal and diabetic human kidneys.

Authors:  T Melvin; Y Kim; A F Michael
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

7.  Uremia in diabetics: the prognosis improves.

Authors:  E A Friedman; M M Beyer
Journal:  Klin Wochenschr       Date:  1980-10-01

8.  Abnormal binding of negatively charged serum proteins to diabetic basement membranes is largely a systemic phenomenon.

Authors:  V Murrah; J Crosson; J Sauk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

9.  Cationised IgM rheumatoid factor: in-vivo glomerular localization and immunoabsorptive capacity in the mouse.

Authors:  P M Ford; I Kosatka
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

10.  Diabetic nephropathy: clinical and histological study in 22 patients.

Authors:  S Bertoli; R Bottelli; R Confalonieri; L Radaelli; C Rovati; G Barbiano di Belgiojoso; G Micoli
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.